Which adults are eligible for telmisartan to reduce cardiovascular morbidity?

Telmisartan is indicated to reduce cardiovascular morbidity in adults with manifest atherothrombotic cardiovascular disease (a history of coronary heart disease, stroke or peripheral arterial disease) or type 2 diabetes mellitus with documented target organ damage.